Margreke J. E. Brill

Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis

Margreke J. E. Brill, Aletta P. I. Houwink, Stephan Schmidt et al. · Journal of Antimicrobial Chemotherapy · 2013 · 138 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Midazolam Pharmacokinetics in Morbidly Obese Patients Following Semi-Simultaneous Oral and Intravenous Administration: A Comparison with Healthy Volunteers

Margreke J. E. Brill, Anne van Rongen, Aletta P. I. Houwink et al. · Clinical Pharmacokinetics · 2014 · 93 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery

Margreke J. E. Brill, Anne van Rongen, Eric P. van Dongen et al. · Pharmaceutical Research · 2015 · 69 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Relationship between the degree of coronary artery disease and of left ventricular function and the duration of the QT-interval in ECG*

B Krämer, Margreke J. E. Brill, Alejandro Bruhn et al. · European Heart Journal · 1986 · 44 citations

Medicine, Cardiology, Internal Medicine +14

Confirming model-predicted pharmacokinetic interactions between bedaquiline and lopinavir/ritonavir or nevirapine in patients with HIV and drug-resistant tuberculosis

Margreke J. E. Brill, Elin M. Svensson, Mishal Pandie et al. · International Journal of Antimicrobial Agents · 2016 · 43 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17